Adrenergic stimulants and asthma mortality.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001249:Asthma / Q000150:complications / Q000401:mortality*; D001980:Bronchi / Q000187:drug effects; D005617:Chlorofluorocarbons, Methane / Q000009:adverse effects; D003251:Constriction, Pathologic; D004351:Drug Resistance; D006801:Humans; D000860:Hypoxia / Q000139:chemically induced; D007545:Isoproterenol / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D005617:Chlorofluorocarbons, Methane; D013566:Sympathomimetics; D007545:Isoproterenol